Isoforms of free prostate-specific antigen

Isoforms of free prostate-specific antigen

عرض إصدارات أخرى (1)

Detection of prostate-specific antigen remains the mainstay in the early detection of prostate cancer. A problem yet unsolved is the lack of specificity of this organ- but not cancer-specific marker, which generates subsequent, invasive procedures in a high number of patients without detecting prost...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Haese, A, Noldus, J, Steuber, T, Huland, H, Lilja, H
التنسيق:	Journal article
اللغة:	German
منشور في:	2004

مواد مشابهة

[Isoforms of free prostate-specific antigen]
حسب: Haese, A, وآخرون
منشور في: (2004)

Prostate-specific antigen and related isoforms in the diagnosis and management of prostate cancer.
حسب: Haese, A, وآخرون
منشور في: (2004)

Total and gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in serum from patients with prostate cancer or benign prostatic biopsies
حسب: Haese, A, وآخرون
منشور في: (2003)

Total and Gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in serum from patients with prostate cancer or benign prostatic biopsies.
حسب: Haese, A, وآخرون
منشور في: (2003)

Discrimination of benign from malignant prostatic disease by selective measurements of single chain, intact free prostate specific antigen.
حسب: Steuber, T, وآخرون
منشور في: (2002)

Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy.
حسب: Steuber, T, وآخرون
منشور في: (2007)

Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancer.
حسب: Steuber, T, وآخرون
منشور في: (2007)

Association of free-prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissue.
حسب: Steuber, T, وآخرون
منشور في: (2005)

Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/ml.
حسب: Haese, A, وآخرون
منشور في: (2001)

Human glandular kallikrein 2: a potential serum marker for predicting the organ confined versus non-organ confined growth of prostate cancer.
حسب: Haese, A, وآخرون
منشور في: (2000)

Discrimination of prostate cancer from benign disease by selective measurements of serum subfractions of free PSA that are not internally cleaved at Lys145-Lys146
حسب: Nurmikko, P, وآخرون
منشور في: (2002)

Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific antigen (PSA) in men with moderate PSA-elevation in serum.
حسب: Steuber, T, وآخرون
منشور في: (2006)

Inhibition of dendropoiesis by tumor derived and purified prostate specific antigen.
حسب: Aalamian, M, وآخرون
منشور في: (2003)

The role of molecular forms of prostate-specific antigen (PSA or hK3) and of human glandular kallikrein 2 (hK2) in the diagnosis and monitoring of prostate cancer and in extra-prostatic disease.
حسب: Becker, C, وآخرون
منشور في: (2001)

The role of human glandular kallikrein 2 for prediction of pathologically organ confined prostate cancer.
حسب: Haese, A, وآخرون
منشور في: (2003)

Biology of prostate-specific antigen
حسب: Lilja, H
منشور في: (2003)

Biology of prostate-specific antigen.
حسب: Lilja, H
منشور في: (2003)

Identification of prostate-specific antigen (PSA) isoforms in complex biological samples utilizing complementary platforms.
حسب: Végvári, A, وآخرون
منشور في: (2010)

Enhanced discrimination of benign from malignant prostatic disease by selective measurements of cleaved forms of urokinase receptor in serum.
حسب: Piironen, T, وآخرون
منشور في: (2006)

Comparison of predictive accuracy for pathologically organ confined clinical stage T1c prostate cancer using human glandular kallikrein 2 and prostate specific antigen combined with clinical stage and Gleason grade.
حسب: Haese, A, وآخرون
منشور في: (2005)

Editorial comment. Association between glomerular filtration rate, free, total, and percent free prostate-specific antigen.
حسب: Christensson, A, وآخرون
منشور في: (2010)

Cumulative prostate cancer risk assessment with the aid of the free-to-total prostate specific antigen ratio.
حسب: Aus, G, وآخرون
منشور في: (2004)

Targeting free prostate-specific antigen for in vivo imaging of prostate cancer using a monoclonal antibody specific for unique epitopes accessible on free prostate-specific antigen alone.
حسب: Evans-Axelsson, S, وآخرون
منشور في: (2012)

Increase in percent free prostate-specific antigen in men with chronic kidney disease.
حسب: Bruun, L, وآخرون
منشور في: (2009)

Prostate-specific antigen and prostate cancer: prediction, detection and monitoring.
حسب: Lilja, H, وآخرون
منشور في: (2008)

Prediction of tumor heterogeneity in localized prostate cancer.
حسب: Huland, H, وآخرون
منشور في: (2002)

Variation in percentage-free prostate-specific antigen (PSA) with prostate volume, age and total PSA level.
حسب: Törnblom, M, وآخرون
منشور في: (2001)

Testing in serum for human glandular kallikrein 2, and free and total prostate specific antigen in biannual screening for prostate cancer
حسب: Becker, C, وآخرون
منشور في: (2003)

Testing in serum for human glandular kallikrein 2, and free and total prostate specific antigen in biannual screening for prostate cancer.
حسب: Becker, C, وآخرون
منشور في: (2003)

Percent-free prostate specific antigen is elevated in men on haemodialysis or peritoneal dialysis treatment.
حسب: Bruun, L, وآخرون
منشور في: (2003)

Early prostate-specific antigen changes and the diagnosis and prognosis of prostate cancer.
حسب: Botchorishvili, G, وآخرون
منشور في: (2009)

Population-based screening for prostate cancer by measuring free and total serum prostate-specific antigen in Sweden.
حسب: Hugosson, J, وآخرون
منشور في: (2003)

Free-to-total prostate-specific antigen ratio as a predictor of non-organ-confined prostate cancer (stage pT3).
حسب: Aus, G, وآخرون
منشور في: (2003)

Clinical value of human glandular kallikrein 2 and free and total prostate-specific antigen in serum from a population of men with prostate-specific antigen levels 3.0 ng/mL or greater.
حسب: Becker, C, وآخرون
منشور في: (2000)

Circulating biomarkers for prostate cancer.
حسب: Steuber, T, وآخرون
منشور في: (2007)

Rapid elimination by glomerular filtration of free prostate specific antigen and human kallikrein 2 after renal transplantation.
حسب: Bruun, L, وآخرون
منشور في: (2004)

An empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detection.
حسب: Vickers, A, وآخرون
منشور في: (2011)

Taxon-specific evolution of glandular kallikrein genes and identification of a progenitor of prostate-specific antigen.
حسب: Olsson, A, وآخرون
منشور في: (2004)

Imaging androgen receptor signaling with a radiotracer targeting free prostate-specific antigen.
حسب: Ulmert, D, وآخرون
منشور في: (2012)

Molecular insights into substrate specificity of prostate specific antigen through structural modeling.
حسب: Singh, P, وآخرون
منشور في: (2009)